Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations

<p>Dr Jorge Cortes from Georgia Cancer Center at Augusta University discusses patient cases and summarizes current treatment approaches for FLT3- and IDH1/2-mutant acute myeloid leukemia.&nbsp;</p><p>CME information and select publications <a href="https://www.researchtopractice.com/OncologyTodayAML24" rel="noopener noreferrer" target="_blank">here</a>. </p>